All Horizon 2020 articles
-
NewsValneva reports high sustained immune response in adolescents one year after Chikungunya Vaccine
Valneva SE, a specialty vaccine company, has reported further positive Phase 3 data in adolescents for its single-shot chikungunya virus (CHIKV) vaccine, IXCHIQ®, which showed a sustained 98.3% sero-response rate one-year after single vaccination.
-
CareersEarly career scientists team up with biotech firm NCIMB to tackle pesticide toxicity
Biotech company NCIMB, one of the industrial beneficiaries, recently hosted three early career scientists as part of the ARISTO programme which aims to develop tools to assess the toxicity of pesticides on soil microorganisms.